Senate stalling derails bill to fix Canada's law on affordable generic medicines for developing countries.

Abstract

On 26 March 2011, when Parliament was dissolved for a federal election, Bill C-393 died on the Order Paper. The bill addressed flaws in Canada's Access to Medicines Regime (CAMR), which is supposed to facilitate the export of lower-cost medications, including HIV treatments, to developing countries.